Key facts
- Klaris’s last known valuation is $1.5M (Dec 2024).
- It has raised $1.1M; the latest was Seed Round ($1.0M) in Feb 2026.
- Notable investors include Antler, Vento, Alecla7, Meridian Health Ventures.
- Klaris has filed 5 Form Ds with the SEC since 2018, most recently May 2024 ($750K sold to 12 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Klaris
- ·The full record, as it builds
Funding rounds
No funding rounds for Klaris are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Klaris
Developer of an AI-powered compliance platform designed to automate regulatory documentation for medical device companies. The company's platform offers automated compliance checks, consistency reviews, expert-validated guidance, and secure data handling to maintain accurate and up-to-date compliance records, enabling research teams and regulated product developers to reduce manual work, better prepare for audits, and focus time on product innovation.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 3
- Website
- klaris.ai/
- Ownership
- Privately Held (backing)
Klaris doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Klaris shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Klaris in its N-PORT filings yet. We sweep new filings monthly.